Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Return on Sales: 2021-2025

Historic Return on Sales for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to -0.47%.

  • Biofrontera's Return on Sales fell 11.00% to -0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.47%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of -0.48% for FY2024, which is 12.00% up from last year.
  • Per Biofrontera's latest filing, its Return on Sales stood at -0.47% for Q3 2025, which was down 11.67% from -0.42% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Return on Sales registered a high of -0.02% during Q4 2022, and its lowest value of -1.56% during Q4 2021.
  • Over the past 3 years, Biofrontera's median Return on Sales value was -0.48% (recorded in 2024), while the average stood at -0.52%.
  • Its Return on Sales has fluctuated over the past 5 years, first spiked by 154bps in 2022, then tumbled by 57bps in 2023.
  • Biofrontera's Return on Sales (Quarterly) stood at -1.56% in 2021, then skyrocketed by 154bps to -0.02% in 2022, then plummeted by 57bps to -0.59% in 2023, then grew by 11bps to -0.48% in 2024, then declined by 11bps to -0.47% in 2025.
  • Its Return on Sales stands at -0.47% for Q3 2025, versus -0.42% for Q2 2025 and -0.30% for Q1 2025.